Search
Descriptor English: Interferon beta-1a
Descriptor Spanish: Interferón beta-1a
Descriptor interferón beta-1a
Scope note: Subtipo de interferón beta-1 que posee una metionina en la posición 1, una cisteína en la posición 17 y es glucosilada en la posición 80. Funciona como ANTIVIRAL e INMUNOMODULADOR y se utiliza para controlar los síntomas de la ESCLEROSIS MÚLTIPLE RECURRENTE-REMITENTE.
Descriptor Portuguese: Interferon beta-1a
Descriptor French: Interféron bêta-1a
Entry term(s): Avonex
Avonex Pen
Interferon beta 1a
Rebif
beta 1a, Interferon
beta-1a, Interferon
Tree number(s): D12.644.276.374.440.890.275.500
D12.776.467.374.440.890.275.500
D23.529.374.440.890.275.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000068556
Scope note: An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
DE drug effects
DF deficiency
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Pharm Action: Adjuvants, Immunologic
Antineoplastic Agents
Antiviral Agents
Registry Number: XRO4566Q4R
Public MeSH Note: 2016; INTERFERON BETA 1A was indexed under INTERFERON-BETA 1994-2015
History Note: 2016 (1994)
DeCS ID: 55969
Unique ID: D000068556
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2018/03/01
Interferon beta-1a - Preferred
Concept UI M0230367
Scope note An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS.
Preferred term Interferon beta-1a
Entry term(s) Interferon beta 1a
beta 1a, Interferon
beta-1a, Interferon
Avonex Pen - Narrower
Concept UI M000638383
Preferred term Avonex Pen
Rebif - Narrower
Concept UI M0129579
Preferred term Rebif
Avonex - Narrower
Concept UI M0230365
Preferred term Avonex



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey